You are here

  • Home
  • Archive
  • Volume 19, Issue 5
  • Actinomycin D Versus Methotrexate-Folinic Acid as the Treatment of Stage I, Low-Risk Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial

Article metrics

Article menu
Download PDFPDF
Trophoblastic Disease
Actinomycin D Versus Methotrexate-Folinic Acid as the Treatment of Stage I, Low-Risk Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial

 

Online download statistics by month:

Online download statistics by month: December 2018 to April 2024

AbstractFullPdf
Dec 2018400
Jan 20191000
Feb 20191200
Mar 20192201
Apr 20191500
May 20192701
Jun 2019600
Jul 20191100
Aug 20192400
Sep 20192300
Oct 20191700
Nov 20191200
Dec 20191904
Jan 20201600
Feb 20202300
Mar 20201801
Apr 20201500
May 20203201
Jun 20203200
Jul 20201802
Aug 20201400
Sep 20202201
Oct 20201900
Nov 20202302
Dec 20201400
Jan 20211700
Feb 20211400
Mar 20211501
Apr 20211001
May 20212801
Jun 2021301
Jul 2021302
Aug 2021100
Oct 20213303
Nov 20211601
Dec 20215004
Jan 20224700
Feb 20221400
Mar 20227501
Apr 20224704
May 20227501
Jun 20225700
Jul 20224300
Aug 20225701
Sep 20228101
Oct 20226702
Nov 20224000
Dec 20222500
Jan 20236000
Feb 20238200
Mar 20234201
Apr 20233200
May 20231200
Jun 2023900
Jul 20233700
Aug 20231602
Sep 20232303
Oct 20232200
Nov 20233600
Dec 20234800
Jan 20241000
Feb 2024800
Mar 20241903
Apr 20242400
Total1746046